This inventor holds 1 USPTO granted patent. Top assignee: Coriolis Pharma Research Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tim Menzen and Machine-Learning-Based Cell Analysis.
Introduction
Tim Menzen is an inventor based in Martinsried, Germany. His patent work concerns the use of machine learning to analyze cell-based product samples and identify viable cells and particulate impurities.
Latest Patents
Menzen is associated with one patent, titled “FIM-CNN for Detection of Viable Cells and/or Particulate Impurities.” The disclosed method uses a convolutional neural network trained on classified flow-imaging microscopy images to quantify viable cells and distinguish them from different types of impurities in a cell-based product sample. 1 patent.
Career Highlights
Menzen works at Coriolis Pharma Research GmbH. His patent reflects an application of image classification technology to the analysis of cell-based products.
Collaborations
His named coworkers include Alexandra Roesch and Andrea Hawe. The patent’s described approach combines flow-imaging microscopy with a trained neural network for cell and impurity classification.
Conclusion
Tim Menzen’s patent work highlights how machine learning can support the detection and quantification of viable cells and particulate impurities in cell-based product samples.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile